Skip to main content
. 2010 Dec 9;286(9):7439–7456. doi: 10.1074/jbc.M110.184382

FIGURE 6.

FIGURE 6.

Modulation of the activated type I TGF-β receptor·SMAD complex by B-MYB. HEK293 cells were transfected with the indicated combinations of plasmid vectors expressing GST-tagged TβR1(TD), an activated type I TGF-β receptor, FLAG-SMAD3, FLAG-SMAD7, and FLAG-tagged wild-type B-MYB or its deletion mutants (DBD, 373/468, TA, and R1), and the cell lysates were subjected to precipitation with glutathione-Sepharose beads (GST purification). Complex formation between TβR1(TD) and SMAD3 (A, left and middle, top panels) or TβR1(TD) and SMAD7 (B, left and middle, top panels) was determined by anti-FLAG antibody immunoblot. The expression level of GST-TβR1(TD) in GST precipitates was determined by anti-GST antibody immunoblot (A and B, left and middle, second panels). HEK293 cells were transfected with the indicated siRNA duplexes (B-MYB siRNAs (#1 and #2) or control scrambled siRNA (Sc)), together with plasmid vectors expressing GST-TβR1(TD), FLAG-SMAD3, or FLAG-SMAD7, and complex formation between TβR1(TD) and SMAD3 (A, right) or TβR1(TD) and SMAD7 (B, right) was determined by anti-FLAG antibody immunoblot (IB). The knockdown of endogenous B-MYB was determined by anti-B-MYB immunoblotting (A and B, right, bottom panels).